Miller Wayne L, Skidan Viktoria I, Pislaru Sorin V, Nkomo Vuyisile T
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States.
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H515-H520. doi: 10.1152/ajpheart.00415.2025. Epub 2025 Jul 11.
The clinical significance of right ventricular dysfunction (RVD) and concomitant blood volume expansion (BVE) in chronic left-sided heart failure (HF) is not well characterized. Accordingly, we assessed the relationship of RVD severity to quantitative measures of blood volume (BV) on clinical outcomes. BV was measured in 150 clinically euvolemic patients at hospital discharge using nuclear medicine indicator-dilution methodology. Patients were stratified by severity of RVD and BVE ≥+25% of normal volume. Data were analyzed for the association of RVD and BVE to composite outcome (HF-related mortality/1st rehospitalization) at 1-year postindex hospitalization. Absolute BV was larger in patients with ≥ moderate RVD ( = 80) compared with normal right ventricle (RV) function ( = 36) (6.8 ± 1.6 vs. 6.1 ± 1.5 L, = 0.029). Distribution of BV profiles within the two subgroups, however, varied significantly. BVE was demonstrated in 59% of patients with RVD [compared to 33% with normal RV ( = 0.010)] and normal BV in 25% with RVD {compared to 44% with normal RV (0.042)]. Kaplan-Meier and Cox regression analyses support BVE with erythrocythemia (relative to normal) as an independent predictors of better composite outcomes ( = 0.037), whereas RVD was not associated with an additional increase in risk ( = 0.137). This prospective analysis demonstrated a high prevalence of RVD (76% of cohort) and BVE (51%) at hospital discharge. Importantly, BVE with erythrocythemia was associated with better composite outcomes despite a high prevalence of RVD, whereas RVD alone was not a predictor of further risk. This suggests that BVE may serve as an adaptive response in part compensating RVD in chronic left-sided HF. This analysis provides a novel assessment of the relationship between the severity of right ventricular dysfunction (RVD) and blood volume expansion (BVE) on clinical outcomes in patients with chronic left-sided heart failure. Findings demonstrate that despite the high prevalence of moderate or greater RVD, persistent BVE was associated with better 1-year event-free survival relative to normal BV. Hypothesis-generating, this suggests that BVE may provide an adaptive response compensating in part for the impact of RVD in chronic HF.
慢性左心衰竭(HF)中右心室功能障碍(RVD)和伴随的血容量扩张(BVE)的临床意义尚未得到充分阐明。因此,我们评估了RVD严重程度与血容量(BV)定量指标对临床结局的关系。在150例临床血容量正常的患者出院时,采用核医学指示剂稀释法测量BV。根据RVD严重程度和BVE≥正常容量的+25%对患者进行分层。分析数据以确定RVD和BVE与索引住院后1年的复合结局(HF相关死亡率/首次再住院)之间的关联。与右心室(RV)功能正常的患者(n = 36)相比,RVD≥中度的患者(n = 80)的绝对BV更大(6.8±1.6 vs. 6.1±1.5 L,P = 0.029)。然而,两个亚组内BV分布情况差异显著。59%的RVD患者出现BVE[正常RV患者为33%(P = 0.010)],25%的RVD患者BV正常{正常RV患者为44%(P = 0.042)}。Kaplan-Meier和Cox回归分析支持红细胞增多症伴BVE(相对于正常情况)是更好的复合结局的独立预测因素(P = 0.037),而RVD与风险的额外增加无关(P = 0.137)。这项前瞻性分析表明,出院时RVD(队列的76%)和BVE(51%)的患病率很高。重要的是,尽管RVD患病率很高,但红细胞增多症伴BVE与更好的复合结局相关,而单独的RVD不是进一步风险的预测因素。这表明BVE可能是一种适应性反应,部分补偿慢性左心衰竭中的RVD。该分析对慢性左心衰竭患者右心室功能障碍(RVD)严重程度与血容量扩张(BVE)对临床结局的关系进行了新的评估。研究结果表明,尽管中度或更严重RVD的患病率很高,但相对于正常BV,持续性BVE与更好的1年无事件生存率相关。作为一种产生假设的研究,这表明BVE可能提供一种适应性反应,部分补偿RVD在慢性HF中的影响。